Clinical trial shows gene editing works for β-Thalassaemia, too

Improved gene editing process reactivates the fetal version of a hemoglobin gene.
Source
Ars Technica
Opens original article in a new tab
AI-flagged phrases in this article
These phrases were flagged by our AI models as potential bias indicators.



